HLA-DRB1 and rheumatoid arthritis: Specific HLA alleles, primarily those associated with RA (e.g., HLA-DRB1*04:05), have been linked to an increased risk of ICI-induced arthritis development, suggesting that some cancer patients may have an intensified risk of autoimmunity following treatment with ICIs [126, 127].